Oxford nanoSystems Ltd., a developer of innovative nano coating technologies, announced the launch of the ElectroFlow ETS20 Multi-cell Electrolyzer Test Station and ElectroFlow MTF Multi-cell Electrolyzer Test Fixture. This equipment has been specifically designed to accelerate research and development (R&D) in electrolysis technology.

The demand for green H₂, a clean and storable energy vector produced through electrolysis, is rapidly growing. This surge is driven by its potential to decarbonize various industries and contribute to achieving net-zero emission targets. However, large-scale adoption hinges on reducing the production cost of green H₂, which requires significant advancements in electrolyzer performance.

Oxford nanoSystems’ new products address this critical need by offering material, component and electrolyzer researchers streamlined testing solutions to accelerate the R&D process.

“Our multi-cell test station and fixtures are a unique offering in the market,” said Ian Russell, CEO of Oxford nanoSystems, “They enable users to conduct multiple tests simultaneously under identical conditions, facilitating efficient comparisons of various materials – a critical aspect of successful R&D efforts in electrolyzer development.”

By enabling parallel testing of multiple electrolyzer cells, the ElectroFlow solution provides a significant key benefit: efficient material evaluation. Electrolyzer scientists and engineers can effectively assess the performance of key cell components, such as membranes, electrodes and coatings.

The ElectroFlow ETS20 is also ideal for gaining familiarity with the operating principles of electrolyzer systems, as well as methods for testing and analysis of electrolyzer cells and components.

The ElectroFlow ETS20 and the ElectroFlow MTF were developed to support the rigorous testing processes used for Oxford nanoSystems’ innovative coating technology. “In speaking with customers about our nanoFLUX coating, it has become clear that many have faced challenges with test equipment. Until now, there hasn’t been a solution available to test multiple cells at the same time and under the same conditions,” said Ian Russell.